# Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

> **NCT02479646** · PHASE1 · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 218 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** MYL-1401H
- **BIOLOGICAL:** EU-Neulasta
- **BIOLOGICAL:** US-Neulasta

## Key facts

- **NCT ID:** NCT02479646
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2022-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02479646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02479646, "Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02479646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*